Variant report

Variant	nsv897930
Chromosome Location	chr11:75960472-76027936
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:58)
LncRNA
region (count:12)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:58 , 50 per page) page: 1 2

No.	Distal block	Cell Line	Cell type
1	chr11:75972540..75975246-chr11:75987093..75989847,2	K562	blood:
2	chr11:75957514..75961654-chr11:75963107..75966623,4	MCF-7	breast:
3	chr11:75949102..75951865-chr11:76018833..76020777,2	MCF-7	breast:
4	chr11:75958075..75960502-chr11:75980599..75982193,2	K562	blood:
5	chr11:75942806..75944926-chr11:75995392..75997134,2	K562	blood:
6	chr11:76025405..76027275-chr11:76028551..76031168,2	MCF-7	breast:
7	chr11:75979986..75982924-chr11:75983377..75985571,2	MCF-7	breast:
8	chr11:75955033..75957194-chr11:75957697..75960592,2	MCF-7	breast:
9	chr11:75985329..75987655-chr11:75988538..75990128,2	MCF-7	breast:
10	chr11:75997658..75999661-chr11:76001528..76004114,2	K562	blood:
11	chr11:75946538..75948469-chr11:75977431..75980028,2	K562	blood:
12	chr11:75996745..75999661-chr11:76001267..76003028,2	K562	blood:
13	chr11:75993624..75995345-chr11:75998194..76000849,2	K562	blood:
14	chr11:75948110..75951119-chr11:75961061..75963529,3	K562	blood:
15	chr11:76018771..76021180-chr11:76023775..76026508,2	MCF-7	breast:
16	chr11:75948250..75950949-chr11:75960338..75963228,2	K562	blood:
17	chr11:76021947..76023516-chr11:76155563..76157533,2	K562	blood:
18	chr11:76013386..76015934-chr11:76018875..76020881,3	K562	blood:
19	chr11:75962755..75964824-chr11:75969509..75971112,2	MCF-7	breast:
20	chr11:75979986..75982924-chr11:75983377..75985571,2	MCF-7	breast:
21	chr11:76018771..76021180-chr11:76023775..76026508,2	MCF-7	breast:
22	chr11:75985329..75987655-chr11:75988538..75990128,2	MCF-7	breast:
23	chr11:75958075..75960502-chr11:75980599..75982193,2	K562	blood:
24	chr11:75997658..75999661-chr11:76001528..76004114,2	K562	blood:
25	chr11:75983339..75985354-chr11:75987123..75988732,2	K562	blood:
26	chr11:75990001..75992230-chr11:75993506..75996094,2	MCF-7	breast:
27	chr11:76013386..76015934-chr11:76018875..76020881,3	K562	blood:
28	chr11:75993624..75995345-chr11:75998194..76000849,2	K562	blood:
29	chr11:75952419..75955189-chr11:75958305..75960702,2	K562	blood:
30	chr11:75945993..75948366-chr11:75966574..75968254,2	MCF-7	breast:
31	chr11:75989853..75992762-chr11:75994483..75997661,3	K562	blood:
32	chr11:75972189..75974283-chr11:75977968..75980667,2	MCF-7	breast:
33	chr11:75990001..75992230-chr11:75993506..75996094,2	MCF-7	breast:
34	chr11:76011233..76013249-chr11:76019708..76021801,2	K562	blood:
35	chr11:75945746..75948974-chr11:75971381..75974996,3	MCF-7	breast:
36	chr11:75984896..75987492-chr11:75991476..75993549,2	K562	blood:
37	chr11:75946144..75948013-chr11:75988722..75990456,2	K562	blood:
38	chr11:75972394..75975476-chr11:75975785..75977497,3	K562	blood:
39	chr11:75981422..75982006-chr15:78441261..78442214,2	Hela-S3	cervix:
40	chr11:75989853..75992762-chr11:75994483..75997661,3	K562	blood:
41	chr11:75944192..75946957-chr11:76002542..76005804,3	K562	blood:
42	chr11:75962755..75964824-chr11:75969509..75971112,2	MCF-7	breast:
43	chr11:75987087..75989574-chr11:76007415..76009487,2	K562	blood:
44	chr11:75984896..75987492-chr11:75991476..75993549,2	K562	blood:
45	chr11:75972540..75975246-chr11:75987093..75989847,2	K562	blood:
46	chr11:75918665..75919393-chr11:76002890..76003539,3	MCF-7	breast:
47	chr11:75987087..75989574-chr11:76007415..76009487,2	K562	blood:
48	chr11:75972189..75974283-chr11:75977968..75980667,2	MCF-7	breast:
49	chr11:75972394..75975476-chr11:75975785..75977497,3	K562	blood:
50	chr11:76011233..76013249-chr11:76019708..76021801,2	K562	blood:

(count:12 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-RP11-111M22.2.1-3	chr11:76009557-76009771	NONHSAT023161
2	lnc-RP11-111M22.2.1-4	chr11:75997432-75997612	NONHSAT023158
3	lnc-RP11-111M22.2.1-4	chr11:76002516-76002552	NONHSAT023160
4	lnc-RP11-111M22.2.1-3	chr11:76010247-76010327	NONHSAT023161
5	lnc-RP11-111M22.2.1-4	chr11:75997446-75997612	NONHSAT023159
6	lnc-RP11-111M22.2.1-4	chr11:75999433-76000027	NONHSAT023157
7	lnc-RP11-111M22.2.1-3	chr11:76002865-76002910	NONHSAT023161
8	lnc-RP11-111M22.2.1-4	chr11:75995481-75995673	NONHSAT023159
9	lnc-RP11-111M22.2.1-4	chr11:75995481-75995673	NONHSAT023160
10	lnc-RP11-111M22.2.1-4	chr11:75995481-75995673	NONHSAT023158
11	lnc-RP11-111M22.2.1-4	chr11:75995481-75995673	NONHSAT023157
12	lnc-RP11-111M22.2.1-2	chr11:76017492-76017583	NONHSAT023162

No data

Variant related genes	Relation type
ENSG00000166411	chromatin interactions
ENSG00000255135	chromatin interactions
ENSG00000158636	chromatin interactions

Extended variants
information (count: 3039 )
Associated
traits (count: 97 )

Variant overlapped rSNPs/rCNVs (count:3039 , 50 per page) page: 1 2 3 4 5 6 7 ... 61

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs631948	chr11:75960472-75960473	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	mRNA abundance
2	rs560815249	chr11:75960484-75960485	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs684065	chr11:75960536-75960537	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs539998786	chr11:75960565-75960566	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs558487545	chr11:75960577-75960578	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs559906927	chr11:75960588-75960589	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs183048724	chr11:75960634-75960635	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs202226929	chr11:75960658-75960659	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs35797434	chr11:75960665-75960666	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs568867094	chr11:75960699-75960700	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs59432405	chr11:75960723-75960724	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs548881653	chr11:75960727-75960728	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs568726190	chr11:75960729-75960730	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs201202485	chr11:75960780-75960781	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs548052672	chr11:75960782-75960783	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs146900664	chr11:75960803-75960804	Weak transcription ZNF genes & repeats Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs186971349	chr11:75960820-75960821	Weak transcription ZNF genes & repeats Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs67595291	chr11:75960829-75960830	Weak transcription ZNF genes & repeats Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs370563412	chr11:75960830-75960831	Weak transcription ZNF genes & repeats Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs535453023	chr11:75960866-75960867	Weak transcription ZNF genes & repeats Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs10899182	chr11:75960894-75960895	Weak transcription ZNF genes & repeats Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
22	rs574431145	chr11:75960907-75960908	Weak transcription ZNF genes & repeats Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs10899183	chr11:75960911-75960912	Weak transcription ZNF genes & repeats Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs559941681	chr11:75960951-75960952	Weak transcription ZNF genes & repeats Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs55756944	chr11:75960984-75960985	Weak transcription ZNF genes & repeats Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
26	rs114106711	chr11:75960985-75960986	Weak transcription ZNF genes & repeats Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs386755123	chr11:75960995-75960996	Weak transcription ZNF genes & repeats Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs603503	chr11:75960996-75960997	Weak transcription ZNF genes & repeats Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
29	rs115743594	chr11:75961008-75961009	Weak transcription ZNF genes & repeats Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs71473308	chr11:75961019-75961020	Weak transcription ZNF genes & repeats Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs147965123	chr11:75961034-75961035	Weak transcription ZNF genes & repeats Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs542649662	chr11:75961039-75961040	Weak transcription ZNF genes & repeats Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs588696	chr11:75961040-75961041	Weak transcription ZNF genes & repeats Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs141881812	chr11:75961069-75961070	Weak transcription ZNF genes & repeats Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs111820553	chr11:75961078-75961079	Weak transcription ZNF genes & repeats Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs183282176	chr11:75961095-75961096	Weak transcription ZNF genes & repeats Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs589181	chr11:75961154-75961155	Weak transcription ZNF genes & repeats Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs557951048	chr11:75961190-75961191	Weak transcription ZNF genes & repeats Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs573003856	chr11:75961208-75961209	Weak transcription ZNF genes & repeats Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs11236662	chr11:75961219-75961220	Weak transcription ZNF genes & repeats Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs146922119	chr11:75961223-75961224	Weak transcription ZNF genes & repeats Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs137916421	chr11:75961231-75961232	Weak transcription ZNF genes & repeats Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs533867334	chr11:75961235-75961236	Weak transcription ZNF genes & repeats Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs553613773	chr11:75961266-75961267	Weak transcription ZNF genes & repeats Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs149472039	chr11:75961295-75961296	Weak transcription ZNF genes & repeats Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs373503768	chr11:75961310-75961311	Weak transcription ZNF genes & repeats Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs11603381	chr11:75961316-75961317	Weak transcription ZNF genes & repeats Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs562614670	chr11:75961367-75961368	Weak transcription ZNF genes & repeats Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs371159775	chr11:75961373-75961374	Weak transcription ZNF genes & repeats Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs576099744	chr11:75961374-75961375	Weak transcription ZNF genes & repeats Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:97)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Gastric cancer	17908304	CNVD
Multiple myeloma	20724749	CNVD
Wilms tumour	21544195	CNVD
Autism	22495311	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Non-small cell lung cancer	21385341	CNVD
Intellectual disability	22102821	CNVD
Glioblastoma multiforme	21138945	CNVD
Acute myeloid leukemia	20729466	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	21637783	CNVD
Acute myeloid leukemia	16864856	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	21484798	CNVD
Ewing''s sarcoma	21437220	CNVD
Oral cancer	21386901	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Cervical cancer	21063398	CNVD
Glioblastoma multiforme	19960244	CNVD
Liposarcoma	21253554	CNVD
Neuroblastoma	18923524	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Neuroblastoma	17533364	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Prostate cancer	18632612	CNVD
Smith-Lemli-Opitz syndrome	21572526	CNVD
Glioblastoma multiforme	21080181	CNVD
Multiple myeloma	16461302	CNVD
Cancer	16751803	CNVD
Seminomas	18059402	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Melanoma	18172304	CNVD
Breast cancer	22002566	CNVD
Ductal carcinoma	18381933	CNVD
Retinoblastoma	22278416	CNVD
Breast cancer	20953835	CNVD
oto-dental syndrome	17656375	CNVD
Asthma	21956041	CNVD
Breast cancer	17603634	CNVD
Ovarian neoplasms	16753589	CNVD
Non-small cell lung cancer	20864512	CNVD
Hepatocellular carcinoma	16750200	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	21509527	CNVD
Breast cancer	17001317	CNVD
Oral squamous cell carcinoma	16619035	CNVD
Intracranial aneurysm	16715129	CNVD
Colorectal cancer	16272173	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Colorectal cancer	16882699	CNVD
Berardinelli-seip congenital generalized lipodystrophy	17668395	CNVD
Spinal muscular atrophy	17668395	CNVD
Neonatal seizures	17668395	CNVD
Neonatal seizures	17668391	CNVD
Neuroticism	17667963	CNVD
Cancer	17916600	CNVD
Squamous cell cancer	19047905	CNVD
Multiple endocrine neoplasia type 1	19566914	CNVD
XY sex reversal	17503084	CNVD
Berardinelli-seip congenital generalized lipodystrophy	17668391	CNVD
Maculopathy	17646752	CNVD
Breast cancer	17899364	CNVD
Breast cancer	17157792	CNVD
Esophageal squamous carcinoma	18350619	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Cancer	20164919	CNVD
lymphocytic leukemia	21291569	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Cancer	22183965	CNVD
Melanoma	22183965	CNVD
Breast cancer	16620391	CNVD
Multiple myeloma	17550852	CNVD
Neuroblastoma	18923191	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Multiple myeloma	16616336	CNVD
Myelofibrosis	22110671	CNVD
Prostate cancer	17217626	CNVD
Cancer	22429812	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	21251322	CNVD
Lung cancer	18438408	CNVD
Breast cancer	21364760	CNVD
Breast cancer	21482786	CNVD
Ovarian cancer	20844748	CNVD
Breast cancer	16608533	CNVD
Usher syndrome	18421352	CNVD
Breast cancer	21858162	CNVD
Ovarian cancer	21240255	CNVD

Chromatin state (count:675 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:75947800-75961800	Weak transcription	Right Atrium	heart
2	chr11:75953000-75961000	Weak transcription	Spleen	Spleen
3	chr11:75955000-75967800	Weak transcription	Placenta Amnion	Placenta Amnion
4	chr11:75955600-75967800	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
5	chr11:75959200-75961400	Enhancers	Stomach Mucosa	stomach
6	chr11:75959400-75961800	Enhancers	Hela-S3	cervix
7	chr11:75960200-75960600	Enhancers	Rectal Mucosa Donor 29	rectum
8	chr11:75960200-75961000	Enhancers	Monocytes-CD14+_RO01746	blood
9	chr11:75960200-75964200	Enhancers	Primary monocytes fromperipheralblood	blood
10	chr11:75960400-75960600	Enhancers	Fetal Muscle Leg	muscle
11	chr11:75960400-75961000	Enhancers	Pancreas	Pancrea
12	chr11:75960800-75962800	ZNF genes & repeats	iPS DF 19.11 Cell Line	embryonic stem cell
13	chr11:75961000-75962600	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
14	chr11:75961000-75962600	ZNF genes & repeats	Spleen	Spleen
15	chr11:75961000-75963600	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
16	chr11:75961000-75965200	Weak transcription	Pancreas	Pancrea
17	chr11:75961200-75963200	Enhancers	Skeletal Muscle Female	skeletal muscle
18	chr11:75961400-75961600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
19	chr11:75961600-75961800	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
20	chr11:75961600-75961800	Flanking Active TSS	Adipose Nuclei	Adipose
21	chr11:75961800-75962200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
22	chr11:75961800-75962200	Weak transcription	Hela-S3	cervix
23	chr11:75961800-75963200	Enhancers	Adipose Nuclei	Adipose
24	chr11:75961800-75963200	Enhancers	Right Atrium	heart
25	chr11:75962000-75963200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
26	chr11:75962000-75963400	Enhancers	Primary neutrophils fromperipheralblood	blood
27	chr11:75962000-75963600	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
28	chr11:75962200-75962600	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
29	chr11:75962200-75963000	Enhancers	Hela-S3	cervix
30	chr11:75962400-75962600	Bivalent Enhancer	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
31	chr11:75962400-75962600	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
32	chr11:75962400-75962600	Bivalent Enhancer	Fetal Muscle Trunk	muscle
33	chr11:75962400-75963200	Bivalent Enhancer	Osteobl	bone
34	chr11:75962600-75962800	Enhancers	Brain Inferior Temporal Lobe	brain
35	chr11:75962600-75963200	Enhancers	Skeletal Muscle Male	skeletal muscle
36	chr11:75962600-75963600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
37	chr11:75962600-75983600	Weak transcription	Spleen	Spleen
38	chr11:75962800-75963000	Enhancers	Brain Cingulate Gyrus	brain
39	chr11:75962800-75964000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
40	chr11:75963000-75963200	Enhancers	Fetal Lung	lung
41	chr11:75963000-75963400	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
42	chr11:75963000-75964400	Weak transcription	Brain Cingulate Gyrus	brain
43	chr11:75963000-75964400	Weak transcription	Brain Inferior Temporal Lobe	brain
44	chr11:75963200-75963400	Bivalent Enhancer	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
45	chr11:75963200-75964200	Bivalent Enhancer	Fetal Muscle Trunk	muscle
46	chr11:75963200-75964200	Weak transcription	Skeletal Muscle Male	skeletal muscle
47	chr11:75963200-75964400	Weak transcription	Skeletal Muscle Female	skeletal muscle
48	chr11:75963200-75967800	Weak transcription	Fetal Lung	lung
49	chr11:75963200-75976000	Weak transcription	Right Atrium	heart
50	chr11:75963600-75964200	Enhancers	Monocytes-CD14+_RO01746	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links